drugset / Trial / NCT02103842

Omega-3 Fatty Acids to Combat Sarcopenia

NCT02103842

Phase 1 Completed 24 enrolled Mayo Clinic
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to determine how omega-3 fatty acids influence muscle protein metabolism and mitochondrial physiology in the context of human aging.

Timeline

Start
2014-03
Primary completion
2015-07
Completion
2015-07

Drugs

EvaluationDrugModalityDoseRoute
Subject DOCONEXENT Other / unclassified
Subject Eicosapentaenoic acid Small molecule

Indications